Immunologic Response to Secukinumab in Plaque Psoriasis
Clinical trial NCT02592018 · COMPLETED
Trial details
- NCT number
- NCT02592018
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2018-12-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.